Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib

Clinical trial NCT02733445 · COMPLETED

Trial details

NCT number: NCT02733445
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Myeloid Leukemia (CML)

Start date: 2015-12-01
Primary completion: 2015-12-01
Enrollment: 2650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.